Asthma Acute Clinical Trial
Official title:
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects: Identification of Biomarkers, Response During Virus-induced Exacerbations, and Interaction With Bronchial Epithelial Cells
Asthma is a common chronic bronchial disease affecting 300 million people worldwide. The disease can be severe when it is not managed properly or when it is not controlled by treatments. Asthma is characterized by bronchial inflammation, bronchial hyperreactivity and tissue remodeling. Symptoms include episodes of coughing, dyspnoea and wheezing in relation with bronchial obstruction. The evolution is marked by the occurrence of exacerbations (increase of symptoms), most often triggered by viral infections, mostly due to rhinoviruses. The treatment of asthma is based on inhaled corticosteroid therapy sometimes combined with other treatments that help control the majority of asthma. However, about 10% of patients suffer from persistent symptoms despite these treatments. Natural killer (NK) cells are important actors of the antiviral innate immune response and are present in high numbers in the lungs. However, their role in severe asthma and its virus-induced exacerbations is unknown. The purpose of this work is to characterize NK cells in severe asthma in order to identify molecules expressed differently from control subjects. The goal is to assess whether these molecules could be potential biomarkers of a severe asthma subtype, also known as the endotype, and/or be the molecular control for exacerbation. The advantage of identifying biomarkers for inflammatory diseases lies in their usefulness in establishing a correct diagnosis, monitoring the progress of the disease and the effectiveness of treatments. The secondary objectives are to characterize the activation of NK cells in response to in vitro rhinovirus infection of different types, in monoculture or in a model of interaction with a bronchial epithelium, and identify one or more molecules involved in the interaction between bronchial epithelial cells and NK cells.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Not yet recruiting |
NCT03277170 -
Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
|
Phase 2 | |
| Completed |
NCT05318885 -
The Effect of Nebulization Positions in Asthmatic Children
|
N/A | |
| Enrolling by invitation |
NCT06171932 -
Comparison Of Efficacy Of Hydrocortisone And Methyl Prednisolone In Acute Severe Asthma
|
||
| Not yet recruiting |
NCT06360185 -
Retrospective Study of Patients With Acute Presentation for Asthma to an Emergency Department in UK (RAPAE)
|
||
| Completed |
NCT03084016 -
Asthma Breath Biomarker Assessment
|
||
| Not yet recruiting |
NCT03296579 -
Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma
|
N/A | |
| Completed |
NCT03154762 -
Anti-inflammatory Effect of Nocturnal NIPPV on Acute Asthma
|
N/A | |
| Enrolling by invitation |
NCT04033666 -
Analysis of Non-invasive Ventilatory Support Modes: High Flow Nasal Cannula and Non-invasive Ventilation
|
N/A | |
| Completed |
NCT03642418 -
User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients
|
||
| Not yet recruiting |
NCT06377345 -
Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
|
N/A |